Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics

Published:2022-12 Issue: Volume:70 Page:102203
ISSN:1369-5274
Container-title:Current Opinion in Microbiology
language:en
Short-container-title:Current Opinion in Microbiology

Author:

Vita Nicole A,Anderson Shelby M,LaFleur Michael D,Lee Richard E

Funder

National Institute of Allergy and Infectious Diseases

St. Jude Children's Research Hospital

National Institutes of Health

American Lebanese Syrian Associated Charities

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Microbiology

Reference49 articles.

1. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis;Hooi;Gastroenterology,2017

2. , Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis;Tacconelli;Lancet Infect Dis,2018

3. Tracking the Global Pipeline of Antibiotics in Development;Trust,2021

4. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis;de Martel;Lancet Oncol,2012

5. Global burden of gastric cancer attributable to Helicobacter pylori;Plummer;Int J Cancer,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and evolution of berberine analogues as anti-Helicobacter pylori agents with multi-target mechanisms;Bioorganic Chemistry;2024-10

2. Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection;Expert Opinion on Investigational Drugs;2024-03-27

3. Antimicrobial combinations against Helicobacter pylori including benzoxadiazol-based flavodoxin inhibitors: in vitro characterization;Microbiology Spectrum;2024-01-11

4. Helicobacter pylori CAs inhibition;The Enzymes;2024

5. New Drug Discovery;Multidisciplinary Applications of Natural Science for Drug Discovery and Integrative Medicine;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3